{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:32:47Z","timestamp":1790706767335,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.eplepsyres.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T09:16:45Z","timestamp":1108113405000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase"],"prefix":"10.1016","volume":"63","author":[{"given":"Richard P.","family":"Shank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Doose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Streeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2005.01.001_bib1","unstructured":"Altman, P.L., 1961. In: Dittmer, D.S. (Eds.), Blood and Other Body Fluids. Fed. Am. Soc. Exp. Biol., Washington, DC, pp. 65, 109."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00003088-200443120-00001","article-title":"Pharmacokinetic interactions of topiramate","volume":"43","author":"Bialer","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1471-4159.1976.tb01559.x","article-title":"Brain carbonic anhydrase: activity in isolated myelin and the effect of hexachlorophene","volume":"27","author":"Cammer","year":"1976","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0960-894X(03)00029-5","article-title":"Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates\/sulfamides with isozymes I, II and IV","volume":"13","author":"Casini","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1528-1157.2000.tb06047.x","article-title":"Topiramate as an inhibitor of carbonic anhydrase isozymes","volume":"41","author":"Dodgson","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/j.1552-4604.1996.tb04754.x","article-title":"Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug","volume":"36","author":"Doose","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib8","series-title":"Antiepileptic Drugs","first-page":"727","article-title":"Topiramate\u2014chemistry, biotransformation and pharmacokinetics","author":"Doose","year":"2002"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archopht.1977.04450080088009","article-title":"Carbonic anhydrase inhibitor side effects","volume":"95","author":"Epstein","year":"1978","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1152\/jappl.1975.38.4.710","article-title":"Time course of exchanges between red cells and extracellular fluid during CO2 uptake","volume":"38","author":"Forster","year":"1975","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1021\/jm011131t","article-title":"Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design","volume":"45","author":"Francesco","year":"2002","journal-title":"J. Med. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1111\/j.1528-1157.2000.tb02174.x","article-title":"Clinical pharmacology of topiramate: a review","volume":"41","author":"Garnett","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib13","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","article-title":"Therapeutic drug monitoring of the newer antiepileptic drugs","volume":"25","author":"Johannessen","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib15","series-title":"The Carbonic Anhydrases: Cellular Physiology and Molecular Genetics","first-page":"49","article-title":"Carbonic anhydrase kinetics and molecular function","author":"Khalifah","year":"1991"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/jm0109199","article-title":"Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties","volume":"45","author":"Maseree","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib17","first-page":"1029","article-title":"Estimation of the absolute bioavailability of topiramate in human without intravenous data","volume":"34","author":"Nayak","year":"1994","journal-title":"J. Clin. Pharmacol."},{"issue":"Suppl. 9","key":"10.1016\/j.eplepsyres.2005.01.001_bib18","first-page":"S7","article-title":"The clinical pharmacokinetics of the new antiepileptic drugs","volume":"40","author":"Perucca","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/bi00855a005","article-title":"The catalytic versatility of erythrocyte carbonic anhydrase. III. Kinetic studies of the enzyme-catalyzed hydrolysis of p-nitrophenyl acetate","author":"Pocker","year":"1967","journal-title":"Biochemistry"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib20","series-title":"Basic and Clinical Pharmacology","first-page":"379","article-title":"Antiseizure drugs","author":"Porter","year":"2004"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0731-7085(98)00137-X","article-title":"A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood","volume":"19","author":"Riffitts","year":"1999","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib22","series-title":"Clinical Pharmacokinetics","author":"Rowland","year":"1995"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1528-1157.1994.tb02459.x","article-title":"Topiramate: preclinical evaluation of a structurally novel anticonvulsant","volume":"35","author":"Shank","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0034-5687(78)90018-X","article-title":"A quantitative analysis of CO2 transport at rest and during maximal exercise","volume":"35","author":"Swenson","year":"1978","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib25","first-page":"161","article-title":"A study of the release of carbon dioxide gas from carbonated beverages","volume":"46","author":"Talbot","year":"1998","journal-title":"Microscope"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1432-1033.1967.tb19504.x","article-title":"Studies of the esterase activity and the anion inhibition of bovine zinc and cobalt carbonic anhydrases","volume":"3","author":"Thorslund","year":"1967","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2165\/00023210-200317130-00007","article-title":"Topiramate as monotherapy in newly diagnosed epilepsy","volume":"17","author":"Waugh","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1748-1716.1981.tb06918.x","article-title":"The importance of carbonic anhydrase B and C for the unloading of CO2 by the human erythrocyte","volume":"113","author":"Wistrand","year":"1981","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.eplepsyres.2005.01.001_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01062109","article-title":"Statistical moments in pharmacokinetics","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:14:20Z","timestamp":1760274860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121105000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":29,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0920121105000021"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.01.001","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}